Effective treatment for diabetes depends on the underlying cause

October 16, 2003

A study in this week's issue of THE LANCET suggests that the underlying cause of diabetes is important in determining how well diabetic patients respond to drug therapy.

Type 2 diabetes is an increasing health burden with over 150,000,000 people affected worldwide. Control of blood glucose is the main therapeutic goal for people with type 2 (non-insulin dependent) diabetes. Most patients on drug treatment receive sulphonylurea drugs, or metformin, or both. Guidelines for treatment assume that all patients with diabetes respond similarly to treatment. No previous studies have assessed whether different causes of diabetes change the response to oral hypoglycaemic therapy.

A genetic sub-type of diabetes is caused by mutations in the hepatocyte nuclear factor-1alpha (HNF-1 a) gene. Ewan Pearson and Andrew Hattersley from the Peninsular Medical School, Exeter, UK, and colleagues assessed whether the glycaemic response to the sulphonylurea gliclazide and the biguanide metformin differed among patients with HNF-1a type 2 diabetes and patients with type 2 diabetes where there was not a defined cause.

Patients from both groups had a similar degree of obesity and similar blood glucose concentrations. Those patients with HNF-1a type 2 diabetes had around a fivefold greater response to gliclazide than to metformin while patients without a defined cause for their type 2 diabetes responded similarly to the two treatments. The sulphonylurea response in HNF-1a patients was fourfold greater than the response in type 2 diabetes.

Andrew Hattersley comments: "We have shown that the cause of diabetes determines the response to hypoglycaemic drugs; with a genetic subtype of diabetes being very sensitive to the effects of sulphonylureas. This knowledge is crucial in deciding the best treatment for individual patients. The individualisation of patients treatment is an important goal of the major work to define the genetic and environmental causes of diabetes"
Contact: Professor Andrew T Hattersley, Diabetes and Vascular Medicine, Peninsula Medical School, Barrack Road, Exeter EX2 5AX UK;
T) 44-139-240-3089;
F) 44-139-240-3027;
E) A.T.Hattersley@ex.ac.uk


Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.